Oncology Imaging Scientist

GSK•Upper Providence Township, PA

22h•Hybrid

About The Position

The Oncology Imaging Scientist is responsible for ensuring high-quality imaging data is integrated into oncology clinical trials. The role supports standardized imaging practices, delivers on imaging strategy across study teams, and ensures imaging endpoints are robust, regulatory-compliant, and enable confident decision-making in drug development. The Oncology Imaging Team’s mission is to deliver imaging strategies that elevate trial quality and reliability, evolve with emerging methods and technologies, and provide the imaging expertise that drives progress across GSK’s oncology portfolio.

Requirements

Bachelor’s degree in a biomedical or imaging-related field with 3+ years of experience
Experience in clinical imaging using multiple radiological imaging modalities (e.g., CT, PET, MRI, scintigraphy) and tumor assessment criteria (e.g., RECIST 1.1, PCWG3, RANO, Lugano, etc.).
Experience with Clinical Trial design and statistics for imaging efficacy endpoints
Experience in authoring scientific articles and clinical trial documents.

Nice To Haves

Medical, Master’s, or PhD degree with imaging experience in radiology, nuclear medicine, or drug development.
CRO/pharma experience in drug development.

Responsibilities

Oversee and deliver imaging endpoints for early- to registrational-phase oncology clinical trials, ensuring high-quality tumor imaging data.
Integrate seamlessly with Oncology Clinical Development study teams as a subject matter expert, performing instream imaging CRF data review and query resolution in collaboration with data management, ensuring consistency in longitudinal tumor assessments according to standard criteria, e.g., RECIST 1.1.
Provide advice and recommendations on standardization of imaging techniques to study teams and Clinical Operations colleagues, ensuring proper implementation and oversight of imaging in oncology clinical trials.
Network within GSK’s matrix environment to identify and meet stakeholder needs. Devise and present imaging strategies that improve drug development decision-making to progress assets through the oncology pipeline.
Evaluate and implement cutting-edge imaging techniques such as AI, ML, GenAI/LLM, radiomic, and tumor growth kinetic methodologies.
Work closely with cross-functional study teams (e.g., Clinical, Operations, Data Management, Quality, Biostats, Regulatory) and advanced technology groups (AI/ML) to define and implement registrational imaging endpoint strategies and advanced analytical methods for robust characterization of tumor response in oncology trials.
Build and maintain relationships with key external imaging experts from industry, imaging Contract Research Organizations (CROs), and academic institutions to support oncology-specific imaging needs. Represent GSK in oncology imaging forums, external meetings and consortia.
Maintain a state-of-the-art knowledge of advances in oncology imaging and translate advanced imaging techniques from leading academic centers to multicenter settings, ensuring quality and consistency across sites.
Develop presentations and deliver training on study imaging requirements and oncology response criteria to study teams, Investigator Meetings, and CRA Trainings. Provide standardized technical documentation tailored to tumor type and modality (e.g., protocol language, acquisition manuals, imaging charters).
Lead GSK’s partnerships with best-in-class imaging CROs by establishing robust operational governance, standardized documentation, and efficient workflows to ensure timely execution and accurate delivery of high-quality blinded independent central review (BICR) imaging data.